scholarly article | Q13442814 |
P356 | DOI | 10.1016/0090-4295(94)90221-6 |
P698 | PubMed publication ID | 8116135 |
P2093 | author name string | L Weissbach | |
A Hinke | |||
M W Kühn | |||
P433 | issue | 2 Suppl | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | metastatic prostate carcinoma | Q55779807 |
prostate cancer | Q181257 | ||
P304 | page(s) | 61-67 | |
P577 | publication date | 1994-02-01 | |
P1433 | published in | Urology | Q7900884 |
P1476 | title | Primary therapy of metastatic prostate carcinoma with depot gonadotropin-releasing hormone analogue goserelin versus estramustine phosphate. The Prostate Cancer Study Group | |
P478 | volume | 43 |
Q56519091 | Estramustine Phosphate Sodium |
Q28290608 | Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer |
Q38574476 | Goserelin. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in prostate cancer |
Q34393961 | How is androgen-dependent metastatic prostate cancer best treated? |
Q77522861 | Systemic treatment for prostate cancer |
Search more.